Literature DB >> 10523731

Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine.

C Roeder1, P V Driesch.   

Abstract

We present the case of a 59-year-old male patient who developed lesions of a bullous pemphigoid during the course of a long-lasting severe psoriasis which had been treated for years with different topical treatments as well as with PUVA and UV-B radiations. Our patient was successfully treated with a combination of acitretin and azathioprine (follow up 28 months). Our case shows that it is possible to avoid systemic corticosteroid treatment in this difficult therapeutic situation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523731

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

Review 1.  Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2022-08-14       Impact factor: 6.233

2.  Coincidence of Bullous Pemphigoid and Pityriasis Rubra Pilaris.

Authors:  Irina Gasslitter; Judith Löffler-Ragg; Enno Schmidt; Matthias Schmuth; Robert Gruber
Journal:  Acta Derm Venereol       Date:  2022-03-22       Impact factor: 3.875

Review 3.  Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.

Authors:  Yosuke Mai; Wataru Nishie; Kazumasa Sato; Moeko Hotta; Kentaro Izumi; Kei Ito; Kazuyoshi Hosokawa; Hiroshi Shimizu
Journal:  Front Immunol       Date:  2018-04-12       Impact factor: 7.561

Review 4.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

5.  Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin.

Authors:  Xiaoqing Si; Lingzhi Ge; Hongyan Xin; Wang Cao; Xiaohui Sun; Wenfei Li
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.